News from orexigen therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 13, 2014, 08:30 ET

Orexigen Therapeutics to Present at the Wells Fargo Securities 2014 Healthcare Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Wells Fargo Securities...

Jun 11, 2014, 06:30 ET

Orexigen Receives Three Month Extension of FDA NB32 Review

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the United States Food and Drug Administration (FDA) has extended its...

Jun 02, 2014, 08:00 ET

Orexigen Announces June 11, 2014 PDUFA Action Date for NB32

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), today announced that the United States Food and Drug Administration (FDA) has informed the...

May 09, 2014, 16:30 ET

Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Bank of America...

May 08, 2014, 16:01 ET

Orexigen Therapeutics Reports Corporate and Financial Results for the First Quarter Ended March 31, 2014

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and...

May 01, 2014, 08:30 ET

Orexigen Therapeutics to Host First Quarter 2014 Financial Results Conference Call and Webcast

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce...

Mar 12, 2014, 16:01 ET

Orexigen Therapeutics Reports Corporate and Financial Results for the Fourth Quarter and Year Ended December 31, 2013

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate...

Mar 03, 2014, 08:30 ET

Orexigen Therapeutics to Host Full Year and Fourth Quarter 2013 Financial Results Conference Call and Webcast

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will...

Feb 27, 2014, 08:30 ET

Orexigen Therapeutics to Present at the 34th Annual Cowen and Co. Health Care Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the 34th Annual Cowen and Co....

Feb 25, 2014, 08:00 ET

Orexigen Provides Update on Its NB32 European Marketing Authorization Application

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company received the Day 120 List of Questions (LoQs) regarding its...

Feb 06, 2014, 08:30 ET

Orexigen Therapeutics to Present at Upcoming Investor Conferences

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will be presenting at two upcoming investor...

Jan 07, 2014, 08:00 ET

Orexigen Announces June 10, 2014 PDUFA Action Date for Contrave

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX), today announced that the United States Food and Drug Administration (FDA) considers the...

Jan 06, 2014, 16:30 ET

Orexigen Therapeutics to Present at the J.P. Morgan 2014 Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the J.P. Morgan 2014 Healthcare...

Dec 11, 2013, 08:00 ET

Orexigen Resubmits Contrave New Drug Application

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that the Company has resubmitted the Contrave® New Drug Application to the...

Dec 06, 2013, 10:45 ET

Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on the treatment of obesity, today...

Dec 03, 2013, 07:12 ET

Orexigen Therapeutics, Inc. Prices Offering of $100 Million of Convertible Senior Notes

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on the treatment of obesity, today announced...

Dec 02, 2013, 07:00 ET

Orexigen Therapeutics, Inc. Proposed Offering of $100 Million of Convertible Senior Notes

 Orexigen® Therapeutics, Inc. (Nasdaq: OREX) (the "Company"), a biopharmaceutical company focused on...

Nov 27, 2013, 16:01 ET

Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the 25th Annual Piper Jaffray...

Nov 25, 2013, 07:01 ET

Orexigen Announces Successful Interim Analysis of Contrave Light Study

Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced successful results of the interim analysis of the Light Study. Based on these results,...

Nov 24, 2013, 18:30 ET

Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast

Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, will announce results...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge